Centerpoint Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-19
Closed -$1K 431
2022
Q1
$1K Hold
19
﹤0.01% 376
2021
Q4
$2K Buy
+19
New +$2K ﹤0.01% 343